Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Straaten, R.J.H.M. van der"'
Autor:
Groot, S. de, Charehbili, A., Laarhoven, H.W.M. van, Mooyaart, A.L., Dekker-Ensink, N.G., Ven, S. van de, Janssen, L.G.M., Swen, J.J., Smit, V.T.H.B.M., Heijns, J.B., Kessels, L.W., Straaten, R.J.H.M. van der, Bhringer, S., Gelderblom, A.J., Hoeven, J.J.M. van der, Guchelaar, H.J., Pijl, H., Kroep, J.R.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::26d97f82d21dac25f7810988b4908ed3
https://hdl.handle.net/1887/99410
https://hdl.handle.net/1887/99410
Publikováno v:
British Journal of Clinical Pharmacology, 78(4), 768-769
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::d0526766886671bb41580b65091eb803
https://hdl.handle.net/1887/104690
https://hdl.handle.net/1887/104690
Publikováno v:
European Journal of Cancer, 49, S495-S495
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::c366a3f3a70b79052911bf685a3274de
https://hdl.handle.net/1887/101386
https://hdl.handle.net/1887/101386
Autor:
Krens, L.L.
Publikováno v:
None
The use of the epidermal growth factor receptor (EGFR) antibodies cetuximab and panitumumab is limited to colorectal cancer (CRC) patients with KRAS wild type tumors and more recently in RAS wild type only. After having become chemotherapy refractory
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::0c0deb31dc5c1bfb842bc7cfdba4ecb7
https://hdl.handle.net/1887/33832
https://hdl.handle.net/1887/33832